These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29162389)

  • 41. Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study.
    Xiong J; Wang J; Huang J; Sun W; Wang J; Chen D
    Clinics (Sao Paulo); 2015 Aug; 70(8):563-8. PubMed ID: 26247669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of Risk Factors for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Patients With Cryptogenic Cirrhosis.
    Bharath Kumar C; Goel A; Jaleel R; David D; Zachariah U; Ramachandran J; Eapen CE
    J Clin Exp Hepatol; 2022; 12(2):492-502. PubMed ID: 35535099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peculiarities of Cirrhosis due to Nonalcoholic Steatohepatitis (NASH).
    El-Sherif O; Armstrong MJ
    Semin Liver Dis; 2020 Feb; 40(1):1-10. PubMed ID: 31537030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis.
    Eshraghian A; Nikeghbalian S; Kazemi K; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA
    HPB (Oxford); 2020 Apr; 22(4):521-528. PubMed ID: 31431413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    VanWagner LB; Lapin B; Skaro AI; Lloyd-Jones DM; Rinella ME
    Liver Int; 2015 Dec; 35(12):2575-83. PubMed ID: 25977117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical presentation and prevalence of spontaneous bacterial peritonitis in patients with cryptogenic cirrhosis and features of metabolic syndrome.
    Sorrentino P; Tarantino G; Conca P; Perrella A; Perrella O
    Can J Gastroenterol; 2004 Jun; 18(6):381-6. PubMed ID: 15190393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
    Jun TW; Yeh ML; Yang JD; Chen VL; Nguyen P; Giama NH; Huang CF; Hsing AW; Dai CY; Huang JF; Chuang WL; Roberts LR; Yu ML; Nguyen MH
    Liver Int; 2018 May; 38(5):895-902. PubMed ID: 29045023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds.
    Struben VM; Hespenheide EE; Caldwell SH
    Am J Med; 2000 Jan; 108(1):9-13. PubMed ID: 11059435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
    Ong J; Younossi ZM; Reddy V; Price LL; Gramlich T; Mayes J; Boparai N
    Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cryptogenic cirrhosis in the region where obesity is not prevalent.
    Kojima H; Sakurai S; Matsumura M; Umemoto N; Uemura M; Morimoto H; Tamagawa Y; Fukui H
    World J Gastroenterol; 2006 Apr; 12(13):2080-5. PubMed ID: 16610061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Divergent trajectories of lean
    Qazi-Arisar FA; Uchila R; Chen C; Yang C; Chen SY; Karnam RS; Azhie A; Xu W; Galvin Z; Selzner N; Lilly L; Bhat M
    World J Gastroenterol; 2022 Jul; 28(26):3218-3231. PubMed ID: 36051335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
    Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients.
    Sanjeevi A; Lyden E; Sunderman B; Weseman R; Ashwathnarayan R; Mukherjee S
    Transplant Proc; 2003 Dec; 35(8):2977-80. PubMed ID: 14697954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.
    Angelico F; Corradini SG; Pastori D; Fargion S; Fracanzani AL; Angelico M; Bolondi L; Tozzi G; Pujatti PL; Labbadia G; Corazza GR; Averna M; Perticone F; Croce G; Persico M; Bucci T; Baratta F; Polimeni L; Del Ben M; Violi F;
    Atherosclerosis; 2017 Jul; 262():179-184. PubMed ID: 28396038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management.
    Vorobioff JD; Contreras F; Tanno F; Hernández L; Bessone F; Colombato L; Adi J; Fassio E; Felgueres M; Fernández G; Gaite L; Gibelli D; Darrichon HG; Lafage M; Lombardo D; López S; Mateo A; Mendizábal M; Pecoraro J; Ruf A; Ruiz P; Severini J; Stieben T; Sixto M; Zárate F; Barraza SB; Sierra ID; Pacheco VR; Roblero JP; Rojas JO; González PR; Rodríguez DSM; Sierralta A; Manchego AU; Valdes E; Yaquich P; Wolff R; Valdivia FB; Gallegos RC; Galloso R; Marcelo JS; Montes P; Tenorio L; Veramendi I; Alava E; Armijos X; Benalcazar G; Carrera E; Pazmiño GF; Díaz EM; Garassini M; Marrero RP; Infante M; Suárez DP; Gutiérrez JC; Reyes CMV; Serrano YM; Hernández RH; Martínez OM; González TP; Andara MT; Hernández MS; Gerona S; García I; Tijera F; López EP; Torres K; Garzón M
    Ann Hepatol; 2020; 19(4):396-403. PubMed ID: 32418749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).
    Tasneem AA; Luck NH; Majid Z
    Trop Doct; 2018 Apr; 48(2):107-112. PubMed ID: 29145775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of α 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation.
    Abu Rmilah A; Fencl R; Watt K; Krowka M; Wiesner R; Murray D; Nyberg S; Leise M
    Transplantation; 2021 Jul; 105(7):1576-1584. PubMed ID: 32732616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease.
    Singal AK; Guturu P; Hmoud B; Kuo YF; Salameh H; Wiesner RH
    Transplantation; 2013 Mar; 95(5):755-60. PubMed ID: 23370710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.